<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">27276254</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1542-0086</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>Biophysical journal</Title><ISOAbbreviation>Biophys J</ISOAbbreviation></Journal><ArticleTitle>Sequence Context Influences the Structure and Aggregation Behavior of a PolyQ Tract.</ArticleTitle><Pagination><StartPage>2361</StartPage><EndPage>2366</EndPage><MedlinePgn>2361-2366</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpj.2016.04.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0006-3495(16)30217-X</ELocationID><Abstract><AbstractText>Expansions of polyglutamine (polyQ) tracts in nine different proteins cause a family of neurodegenerative disorders called polyQ diseases. Because polyQ tracts are potential therapeutic targets for these pathologies there is great interest in characterizing the conformations that they adopt and in understanding how their aggregation behavior is influenced by the sequences flanking them. We used solution NMR to study at single-residue resolution a 156-residue proteolytic fragment of the androgen receptor that contains a polyQ tract associated with the disease spinobulbar muscular atrophy, also known as Kennedy disease. Our findings indicate that a Leu-rich region preceding the polyQ tract causes it to become &#x3b1;-helical and appears to protect the protein against aggregation, which represents a new, to our knowledge, mechanism by which sequence context can minimize the deleterious properties of these repetitive regions. Our results have implications for drug discovery for polyQ diseases because they suggest that the residues flanking these repetitive sequences may represent viable therapeutic targets.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Biophysical Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eftekharzadeh</LastName><ForeName>Bahareh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piai</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CERM and Department of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiesa</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mungianu</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierattelli</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>CERM and Department of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felli</LastName><ForeName>Isabella C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>CERM and Department of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvatella</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain; ICREA, Barcelona, Spain. Electronic address: xavier.salvatella@irbbarcelona.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>648201</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biophys J</MedlineTA><NlmUniqueID>0370626</NlmUniqueID><ISSNLinking>0006-3495</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066241" MajorTopicYN="N">Carbon-13 Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002942" MajorTopicYN="N">Circular Dichroism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067493" MajorTopicYN="N">Dynamic Light Scattering</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019906" MajorTopicYN="N">Nuclear Magnetic Resonance, Biomolecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066244" MajorTopicYN="N">Proton Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">EMS68484</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27276254</ArticleId><ArticleId IdType="mid">EMS68484</ArticleId><ArticleId IdType="pmc">PMC4900447</ArticleId><ArticleId IdType="doi">10.1016/j.bpj.2016.04.022</ArticleId><ArticleId IdType="pii">S0006-3495(16)30217-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zoghbi H.Y., Orr H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 2000;23:217&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">10845064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirkin S.M. Expandable DNA repeats and human disease. Nature. 2007;447:932&#x2013;940.</Citation><ArticleIdList><ArticleId IdType="pubmed">17581576</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K.-Y., Shyu Y.-C., Marsh J.L. Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell&#xa0;models of Huntington&#x2019;s disease. Hum. Mol. Genet. 2015;24:1602&#x2013;1616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4381756</ArticleId><ArticleId IdType="pubmed">25398943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates G.P., Dorsey R., Tabrizi S.J. Huntington disease. Nat. Rev. Dis. Prim. 2015;1:15005.</Citation><ArticleIdList><ArticleId IdType="pubmed">27188817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahl S.J., Weiss L.E., Moerner W.E. Cellular inclusion bodies of mutant huntingtin exon 1 obscure small fibrillar aggregate species. Sci. Rep. 2012;2:895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3508451</ArticleId><ArticleId IdType="pubmed">23193437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalavade R., Griesche N., Krauss S. Mechanisms of RNA-induced toxicity in CAG repeat disorders. Cell Death Dis. 2013;4:e752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3763438</ArticleId><ArticleId IdType="pubmed">23907466</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Huey-Tubman K.E., Bjorkman P.J. The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model. Nat. Struct. Mol. Biol. 2007;14:381&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">17450152</ArticleId></ArticleIdList></Reference><Reference><Citation>Masino L., Kelly G., Pastore A. Solution structure of polyglutamine tracts in GST-polyglutamine fusion proteins. FEBS Lett. 2002;513:267&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">11904162</ArticleId></ArticleIdList></Reference><Reference><Citation>Merry D.E., Kobayashi Y., Fischbeck K.H. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 1998;7:693&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">9499423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelmann E.P. Molecular biology of the androgen receptor. J.&#xa0;Clin. Oncol. 2002;20:3001&#x2013;3015.</Citation><ArticleIdList><ArticleId IdType="pubmed">12089231</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Berthelier V., Wetzel R. Polyglutamine aggregation behavior in&#xa0;vitro supports a recruitment mechanism of cytotoxicity. J.&#xa0;Mol. Biol. 2001;311:173&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">11469866</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellstrand E., Boland B., Linse S. Amyloid &#x3b2;-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem. Neurosci. 2010;1:13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3368626</ArticleId><ArticleId IdType="pubmed">22778803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermel W., Bertini I., Stanek J. Speeding up sequence specific assignment of IDPs. J.&#xa0;Biomol. NMR. 2012;53:293&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">22684679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermel W., Felli I.C., Zawadzka-Kazimierczuk A. High-dimensionality 13C direct-detected NMR experiments for the automatic assignment of intrinsically disordered proteins. J.&#xa0;Biomol. NMR. 2013;57:353&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">24203099</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay L.E., Bax A. New methods for the measurement of NH- C&#x3b1;H constants in 15N-labeled proteins coupling. J.&#xa0;Magn. Reson. 1990;86:110&#x2013;126.</Citation></Reference><Reference><Citation>Piai A., Ho&#x161;ek T., Felli I.C. &#x201c;CON-CON&#x201d; assignment strategy for highly flexible intrinsically disordered proteins. J.&#xa0;Biomol. NMR. 2014;60:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">25326659</ArticleId></ArticleIdList></Reference><Reference><Citation>Clubb R.T., Thanabal V., Wagner G. A constant-time three-dimensional triple-resonance pulse scheme to correlate intraresidue 1HN, 15N, and 13C&#x2032; chemical shifts in 15N&#x2013;13C-labelled proteins. J.&#xa0;Magn. Reson. 1992;97:213&#x2013;217.</Citation></Reference><Reference><Citation>Kazimierczuk K., Zawadzka A., Ko&#x17a;mi&#x144;ski W. Optimization of random time domain sampling in multidimensional NMR. J.&#xa0;Magn. Reson. 2008;192:123&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">18308599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich E.L., Akutsu H., Markley J.L. BioMagResBank. Nucleic Acids Res. 2008;36:D402&#x2013;D408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2238925</ArticleId><ArticleId IdType="pubmed">17984079</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaglio F., Grzesiek S., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J.&#xa0;Biomol. NMR. 1995;6:277&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">8520220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazimierczuk K., Zawadzka A., Zhukov I. Random sampling of evolution time space and Fourier transform processing. J.&#xa0;Biomol. NMR. 2006;36:157&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">17031529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazimierczuk K., Zawadzka-Kazimierczuk A., Ko&#x17a;mi&#x144;ski W. Non-uniform frequency domain for optimal exploitation of non-uniform sampling. J.&#xa0;Magn. Reson. 2010;205:286&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">20547466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazimierczuk K., Zawadzka A., Ko&#x17a;mi&#x144;ski W. Narrow peaks and high dimensionalities: exploiting the advantages of random sampling. J.&#xa0;Magn. Reson. 2009;197:219&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">19185522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kneller D.G., Kuntz I.D. UCSF Sparky: an NMR display, annotation and assignment tool. J.&#xa0;Cell. Biochem. 1993;53:254.</Citation></Reference><Reference><Citation>Vranken W.F., Boucher W., Laue E.D. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins. 2005;59:687&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">15815974</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamiola K., Acar B., Mulder F.A. Sequence-specific random coil chemical shifts of intrinsically disordered proteins. J.&#xa0;Am. Chem. Soc. 2010;132:18000&#x2013;18003.</Citation><ArticleIdList><ArticleId IdType="pubmed">21128621</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamiola K., Mulder F.A. Using NMR chemical shifts to calculate the propensity for structural order and disorder in proteins. Biochem. Soc. Trans. 2012;40:1014&#x2013;1020.</Citation><ArticleIdList><ArticleId IdType="pubmed">22988857</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilloni C., De Simone A., Vendruscolo M. Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. Biochemistry. 2012;51:2224&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pubmed">22360139</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil S., Ho&#x161;ek T., Felli I.C. NMR spectroscopic studies of intrinsically disordered proteins at near-physiological conditions. Angew. Chem. Int. Ed. Engl. 2013;52:11808&#x2013;11812.</Citation><ArticleIdList><ArticleId IdType="pubmed">24115372</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh J.A., Singh V.K., Forman-Kay J.D. Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation. Protein Sci. 2006;15:2795&#x2013;2804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2242444</ArticleId><ArticleId IdType="pubmed">17088319</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P., Watt K., McEwan I.J. Consequences of poly-glutamine repeat length for the conformation and folding of the&#xa0;androgen receptor amino-terminal domain. J.&#xa0;Mol. Endocrinol. 2008;41:301&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">18762554</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan L.E., Carr J.K., Zanni M.T. Structural motif of polyglutamine amyloid fibrils discerned with mixed-isotope infrared spectroscopy. Proc. Natl. Acad. Sci. USA. 2014;111:5796&#x2013;5801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000827</ArticleId><ArticleId IdType="pubmed">24550484</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Ferrone F.A., Wetzel R. Huntington&#x2019;s disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA. 2002;99:11884&#x2013;11889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC129363</ArticleId><ArticleId IdType="pubmed">12186976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya A., Thakur A.K., Wetzel R. Oligoproline effects on polyglutamine conformation and aggregation. J.&#xa0;Mol. Biol. 2006;355:524&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">16321399</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur A.K., Jayaraman M., Wetzel R. Polyglutamine disruption of the huntingtin exon 1 N-terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 2009;16:380&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2706102</ArticleId><ArticleId IdType="pubmed">19270701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellisdon A.M., Thomas B., Bottomley S.P. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J.&#xa0;Biol. Chem. 2006;281:16888&#x2013;16896.</Citation><ArticleIdList><ArticleId IdType="pubmed">16624810</ArticleId></ArticleIdList></Reference><Reference><Citation>Calloni G., Lendel C., Chiti F. Structure and dynamics of a partially folded protein are decoupled from its mechanism of aggregation. J.&#xa0;Am. Chem. Soc. 2008;130:13040&#x2013;13050.</Citation><ArticleIdList><ArticleId IdType="pubmed">18767849</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherzinger E., Sittler A., Wanker E.E. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington&#x2019;s disease pathology. Proc. Natl. Acad. Sci. USA. 1999;96:4604&#x2013;4609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16379</ArticleId><ArticleId IdType="pubmed">10200309</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>